Urothelial/bladder cancer (FGFR SNV/fusions) [Tissue]
FGFR3 testing (SNVs and gene fusions) in Urothelial / Bladder cancer (FFPE)
Pan-Tumour Fusions [FFPE]
Fusion gene testing for fusions relevant to therapy (ALK, ROS1, RET, NTRK1, NTRK2, NTRK3, FGFR1, FGFR2, or FGFR3) for solid cancers (FFPE)
Homologous Recombination Deficiency (HRD) testing in ovarian cancer [Tissue]
HRD testing for Ovarian Cancer (Tissue). This EQA is sponsored.
Lung Cancer (NSCLC) [Plasma]
EGFR, BRAF and KRAS testing of cfDNA (plasma) for NSCLC. This EQA is sponsored.
Lung Cancer (NSCLC) [Tissue]
This EQA has two modules: COMMON BIOMARKERS (mandatory to participate in this EQA) and NEW & EMERGING BIOMARKERS (optional to participate in this EQA) both using FFPE to test.
Melanoma [Tissue]
BRAF, NRAS and KIT gene testing in melanoma (FFPE).